↓ Skip to main content

Dove Medical Press

Profile of sarilumab and its potential in the treatment of rheumatoid arthritis

Overview of attention for article published in Drug Design, Development and Therapy, May 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

patent
4 patents
wikipedia
5 Wikipedia pages

Readers on

mendeley
137 Mendeley
Title
Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
Published in
Drug Design, Development and Therapy, May 2017
DOI 10.2147/dddt.s100302
Pubmed ID
Authors

Maria Gabriella Raimondo, Martina Biggioggero, Chiara Crotti, Andrea Becciolini, Ennio Giulio Favalli

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Belgium 1 <1%
Unknown 136 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 15%
Student > Master 16 12%
Student > Ph. D. Student 13 9%
Researcher 10 7%
Student > Postgraduate 10 7%
Other 23 17%
Unknown 44 32%
Readers by discipline Count As %
Medicine and Dentistry 28 20%
Pharmacology, Toxicology and Pharmaceutical Science 23 17%
Biochemistry, Genetics and Molecular Biology 11 8%
Immunology and Microbiology 5 4%
Agricultural and Biological Sciences 4 3%
Other 16 12%
Unknown 50 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 May 2022.
All research outputs
#3,799,858
of 25,382,440 outputs
Outputs from Drug Design, Development and Therapy
#249
of 2,268 outputs
Outputs of similar age
#65,829
of 324,557 outputs
Outputs of similar age from Drug Design, Development and Therapy
#4
of 49 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 324,557 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.